The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 18, 2022

Filed:

Nov. 23, 2018
Applicant:

University College Cardiff Consultants Ltd, South Glamorgan, GB;

Inventors:

Riccardo Brambilla, South Glamorgan, GB;

Stefania Fasano, Milan, IT;

Marzia Indrigo, Milan, IT;

Alessandro Papale, Milan, IT;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/45 (2006.01); A61K 45/06 (2006.01); A61K 38/00 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01); C07K 14/00 (2006.01); C12N 9/12 (2006.01);
U.S. Cl.
CPC ...
A61K 38/005 (2013.01); A61P 25/16 (2018.01); A61P 25/28 (2018.01); A61K 45/06 (2013.01);
Abstract

Inhibitors of MAPK3 (ERK1 MAP kinase), in particular polypeptides having the ability to stimulate the global ERK signalling pathway in the brain and their use as neuroprotective and/or cognitive enhancing agents, are disclosed. Related polynucleotides, vectors, host cells and pharmaceutical compositions able to inhibit MAPK3, causing the stimulation of the global ERK signalling pathway, are also disclosed. Additionally, use of the afore inhibitors or stimulators in the treatment of neurodegenerative or neuropsychiatric disorders and cognitive impairment is also disclosed.


Find Patent Forward Citations

Loading…